Abstracts tagged "Quality"

Abstract Number: 169 • 2019 ACR/ARP Annual Meeting
Wikipedia as a Source of Health Information for the Public: Systematic Analysis of Quality and Readability of 8 Common Rheumatic Diseases Articles
Mosaab Mohameden¹, Ali Ali ², Zi Ying Li ², Sehreen Mumtaz ² and Candice Reyes Yuvienco ², ¹University of California San Francisco Fresno, Cincinnati, OH, ²University of California San Francisco Fresno, Fresno, CA
Background/Purpose: Wikipedia is the largest open-access online collaborative encyclopedia. Several studies have shown that Wikipedia is one of the most read online source for health…
Abstract Number: 2041 • 2017 ACR/ARHP Annual Meeting
Practice Improvement Utilizing Six Sigma and Health Informatics in an Academic Setting
Puneet Bajaj¹, Shilu Varghese², Allison Sunleaf², Paul Padilla², Shannon Scielzo², Sherene Philip², Justin Haridas², Clarie Wang², Vaishnavi Kannan², Jeffrey Lewis², Deepa Bhat², Jacqueline Mutz², Duwayne Willett², Jason Fish² and David Karp², ¹Rheumatology, UT Southwestern Medical Center, Dallas, TX, ²UT Southwestern Medical Center, Dallas, TX
Background/Purpose: For projects such as the ACR Rheumatology Informatics System for Effectiveness (RISE) to succeed for quality improvement, practice benchmarking, & research, the data included…
Abstract Number: 142 • 2016 ACR/ARHP Annual Meeting
Quality Assessment of Ultrasound Guided Synovial Biopsies Performed in Clinical Practice
Aurélie Najm¹, Marie-Françoise Heymann², Géraldine Bart¹, Yves Maugars¹ and Benoît Le Goff¹, ¹Rheumatology, Nantes University Hospital, Nantes, France, ²Histopathology, Histopathology, Nantes University Hospital, Nantes, France
Background/Purpose: Synovial tissue is the principal target and end organ involved in the pathogenesis of multiple articular disease processes. Histological and bacteriological analyses of synovial…
Abstract Number: 1920 • 2013 ACR/ARHP Annual Meeting
Determining The Vaccination Rates Of American College Of Rheumatology Recommended Vaccines Among Veterans With Rheumatoid Arthritis – A Quality Indicator
Puneet Bajaj¹, Melinda Collins² and Ranjan Roy¹, ¹Rheumatology, VA Medical Center, Northport, NY, ²Internal Medicine, VA Medical Center, Northport, NY
Background/Purpose: American College of Rheumatology (ACR) guidelines recommends the administration of killed vaccines [pneumococcal, influenza and hepatitis B (HepB)], recombinant human papillomavirus (HPV) vaccine and…
Abstract Number: 1578 • 2013 ACR/ARHP Annual Meeting
Decreased Sensitivity Of a Commercial Anti-dsDNA Assay In Patients With Moderately To Severely Active Systemic Lupus Erythematosus
Munther A. Khamashta¹, Gabor G. Illei², Stephen Yoo², Liangwei Wang³ and Warren Greth², ¹Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom, ²Clinical Development, MedImmune, LLC, Gaithersburg, MD, ³Biostatistics, MedImmune, LLC, Gaithersburg, MD
Background/Purpose: Anti-dsDNA autoantibodies are highly specific for SLE. Anti-dsDNA positivity is an important eligibility criterion in many SLE studies, and decreases in anti-dsDNA levels are…
Abstract Number: 196 • 2013 ACR/ARHP Annual Meeting
Uptake Of The American College Of Rheumatology’s Rheumatology Clinical Registry: Quality Measure Summary Data
Jinoos Yazdany¹, Salahuddin Kazi², Rachel Myslinski³ and Melissa Francisco⁴, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴Registries & Health Informatics, American College of Rheumatology, Atlanta, GA
Background/Purpose: The RCR provides ACR members with an infrastructure for quality reporting related to rheumatoid arthritis, gout, osteoarthritis, osteoporosis, and drug safety. Currently in its…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].